Key Points
Europlasma S.A. (1EZ0.F) crashes 18% intraday on XETRA to €0.0072.
Negative earnings of -€88.61 EPS and -105% net margin signal severe financial distress.
Technical indicators show oversold RSI (37.85) and extreme selling pressure (CCI -118.15).
Company faces existential challenges with negative equity and deteriorating cash flow metrics.
Europlasma S.A. (1EZ0.F) is experiencing severe intraday pressure on XETRA, with shares falling 18.18% to €0.0072. The French waste management company, which specializes in plasma torch systems and hazardous waste treatment, has collapsed dramatically from its 52-week high of €37.00. Trading volume surged to 110,000 shares, significantly above the 63,980-share average. This sharp decline reflects mounting investor concerns about the company’s financial health, negative earnings per share of -€88.61, and deteriorating operational metrics. The stock’s performance underscores the challenges facing smaller industrial firms in the waste management sector.
Why 1EZ0.F Stock Is Collapsing Today
Europlasma S.A. faces a perfect storm of negative fundamentals that triggered today’s sharp selloff. The company reported an EPS of -€88.61, indicating severe losses relative to its share count of 1.84 billion shares outstanding. The stock’s year-to-date decline of -96.43% and one-year loss of -99.98% reveal a company in structural distress.
Earnings and Profitability Crisis
The waste management firm’s net profit margin stands at -105.33%, meaning every euro of revenue generates substantial losses. Operating margins are equally dire at -28.17%, while the company burns cash with free cash flow per share at -€86.34. These metrics explain why institutional investors continue exiting positions, pushing volume 72% above normal levels today.
Technical Breakdown and Market Sentiment
Technical indicators confirm severe downward momentum in 1EZ0.F stock trading. The Relative Strength Index (RSI) sits at 37.85, signaling oversold conditions, while the Commodity Channel Index (CCI) reads -118.15, indicating extreme bearish pressure. Williams %R at -100.00 suggests maximum selling intensity.
Trading Activity and Liquidation
Volume patterns show aggressive liquidation, with 110,000 shares traded against a 63,980-share average. The stock’s day range of €0.0058 to €0.0072 reflects wild intraday swings. On-Balance Volume (OBV) at -161,828 confirms sustained selling pressure. Track 1EZ0.F on Meyka for real-time updates on this deteriorating technical picture.
Price Action and Volatility
The Average True Range (ATR) of €0.01 shows extreme volatility relative to the stock’s micro-cap price. Bollinger Bands have compressed to €0.00-€0.03, indicating a potential breakout. The stock’s 50-day moving average of €0.0227 sits far above current levels, confirming a severe downtrend.
Financial Metrics Paint a Bleak Picture
Europlasma’s balance sheet deterioration explains investor panic. The current ratio of 0.80 indicates the company cannot cover short-term obligations with current assets. Working capital stands at -€13.48 million, showing negative cash flow operations. Debt-to-equity ratio of -0.88 reflects negative shareholder equity, a critical red flag.
Valuation and Profitability Concerns
With a market cap of just €13.63 million and enterprise value of €19.92 million, the company trades at 0.31x sales. However, negative earnings make traditional valuation metrics meaningless. The price-to-book ratio of -0.0001 reflects the company’s negative tangible book value of -€75.91 per share, indicating shareholders face potential total loss.
Meyka AI Grade and Outlook
Meyka AI rates 1EZ0.F with a grade of B and a HOLD recommendation, with a total score of 62.63. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The rating reflects mixed signals: while ROE scores 5 (Strong Buy), DCF, ROA, debt-to-equity, PE, and price-to-book all score 1 (Strong Sell).
Investment Considerations
These grades are not guaranteed and we are not financial advisors. The waste management sector shows average ROA of 5.27% and ROE of 17.21%, but Europlasma significantly underperforms these benchmarks. Investors should conduct thorough due diligence before considering any position in this distressed micro-cap stock.
Final Thoughts
Europlasma S.A. (1EZ0.F) represents an extreme case of a micro-cap industrial stock in severe distress. The 18.18% intraday crash reflects justified market concerns about negative earnings, deteriorating cash flow, and negative shareholder equity. With a market cap of €13.63 million and losses exceeding revenue, the company faces existential challenges. The technical breakdown, oversold RSI, and elevated volume confirm aggressive liquidation by investors. While Meyka AI assigns a HOLD rating, the fundamental metrics suggest extreme caution. Traders and investors should recognize this as a high-risk, speculative situation requiring careful monitoring of any restructuring announcements or strategic developments from management.
FAQs
Europlasma faces severe financial distress with negative earnings (-€88.61 EPS) and deteriorating cash flow. The crash reflects investor liquidation and viability concerns in waste management.
1EZ0.F trades at €0.0072 on XETRA, down from €0.0088 at previous close. The stock has collapsed 99.98% over the past year due to operational and financial deterioration.
No. Europlasma reports a net profit margin of -105.33%, losing money on every euro of revenue. Free cash flow per share is -€86.34 with negative shareholder equity.
Meyka AI assigns a B grade with HOLD recommendation (score: 62.63). Mixed fundamentals show strong ROE but weak DCF, ROA, debt metrics, and valuation. Not financial advice.
1EZ0.F represents extreme risk. Negative earnings, negative equity, and deteriorating cash flow suggest potential total shareholder loss. Speculative micro-cap requiring thorough due diligence.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)